Market Tracker

07/26 6:05am ET

Enzo Biochem Inc (NYSE:ENZ)

6.50
Delayed Data
As of Jul 25
 -0.04 / -0.61%
Today’s Change
2.57
Today|||52-Week Range
6.85
+44.44%
Year-to-Date
Why Juno Therapeutics (JUNO) Could Be Positioned for a Slump
Jul 15 / Zacks.com - Paid Partner Content
5 Low Priced Breakout Stocks with Superlative Returns
Jul 14 / Zacks.com - Paid Partner Content
Should You Get Rid of Emergent BioSolutions (EBS) Now?
Jul 15 / Zacks.com - Paid Partner Content
TrovaGene Inks Partnership with USC Norris Cancer Center
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.54
Today’s open6.52
Day’s range6.40 - 6.54
Volume195,402
Average volume (3 months)264,664
Market cap$302.6M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)+78.26%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+1.72%
P/E ratio17.1
Price/Sales1.39
Price/Book7.07

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...-0.67-1.64%
ARWRArrowhead Pharmaceut...0.000.00%
AVXLAnavex Life Sciences...+0.60+8.75%
NVIVInVivo Therapeutics ...+0.05+0.76%
Data as of 07/25/2016

Financials

Next reporting dateOctober 11, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$97.6M
Annual profit (last year)-$2.3M
Net profit margin-2.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts